Literature DB >> 16958238

Suprahyoid approach to base-of-tongue squamous cell carcinoma.

W Mulwafu1, J J Fagan, R Lentin.   

Abstract

OBJECTIVE: To evaluate the suprahyoid approach to treatment of squamous cell carcinoma of the base of the tongue at Groote Schuur Hospital between 1999 and 2004. DESIGN AND
METHOD: Retrospective analysis was done of patients with base-of-tongue squamous cell carcinoma treated using the suprahyoid approach.
RESULTS: Seventeen patients underwent treatment for base-of-tongue squamous cell carcinoma utilising the suprahyoid approach. Complete medical records were available for 15 of these patients. The most common presenting symptoms were neck mass (40%) and referred otalgia (33%). Alcohol was a risk factor in more patients (64%) than smoking (47%). Adverse pathological findings were present in less than 50% of patients (involved margins 20%, perineural invasion 40%, vascular invasion 33%). Functional outcome in terms of speech intelligibility was excellent and there were minimal swallowing problems, with most patients using compensatory strategies and dietary modification. There were 2 subsequent deaths (13%) as a result of distant metastasis and a second primary.
CONCLUSION: The suprahyoid approach to treatment of base-of-tongue squamous cell carcinoma provides good exposure, local tumour control and excellent functional outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16958238

Source DB:  PubMed          Journal:  S Afr J Surg        ISSN: 0038-2361            Impact factor:   0.375


  3 in total

Review 1.  Controversies in the management of tongue base cancer.

Authors:  J P O'Neill; J P Hughes; K P Manning; J E Fenton
Journal:  Ir J Med Sci       Date:  2008-09-23       Impact factor: 1.568

2.  Myoepithelial carcinoma of the vallecula: A case report and review of the literature.

Authors:  Chenxing Wang; Zhuoyuan Zhang; Longjiang Li
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

3.  A study of the etiology of referred otalgia.

Authors:  Mohammad Hosein Taziki; Nasser Behnampour
Journal:  Iran J Otorhinolaryngol       Date:  2012
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.